|
|
.
See Category: Neoplasms
See Header: Malignant neoplasm of nipple and areola, female
ICD-10 (CM) Code and Descriptor
|
C50.012 |
Malignant neoplasm of nipple and areola, left female breast
Diagnosis Valid for Female Patient Only
|
C50012 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 49.57%
|
24.52%
|
10.65%
|
5.17%
|
3.33%
|
2.23%
|
1.47%
|
0.81%
|
0.65%
|
0.44%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C50.012*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
4,067
|
4,076
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
3,734
|
3,735
|
|
80053
|
COMPREHEN METABOLIC PANEL |
3,641
|
3,641
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
3,110
|
3,117
|
|
86300
|
IMMUNOASSAY TUMOR CA 15-3 |
1,435
|
1,576
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
736
|
736
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
671
|
671
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
511
|
511
|
|
J2405
|
ONDANSETRON HCL INJECTION |
490
|
2,806
|
|
77066
|
DX MAMMO INCL CAD BI |
490
|
490
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
486
|
44,413
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
484
|
928
|
|
77065
|
DX MAMMO INCL CAD UNI |
479
|
480
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
478
|
4,104
|
|
J3010
|
FENTANYL CITRATE INJECTION |
474
|
772
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
462
|
681
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
453
|
467
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
445
|
660
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
441
|
20,664
|
|
83735
|
ASSAY OF MAGNESIUM |
436
|
437
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C50.012 related to the following DRG Codes:
582-583
597-599
|
